Related Experiment Video
Updated: Sep 29, 2025

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
Published on: March 24, 2017
[New and rediscovered treatments for tuberculosis]
Christian Kraef1, Troels Lillebæk2,3, Åse Bengård Andersen1
1Afdeling for Infektionssygdomme, Hjertecentret, Københavns Universitetshospital - Rigshospitalet.
New tuberculosis treatments offer shorter, oral regimens for drug-susceptible and resistant TB. Future approaches combine these advances with precision medicine for improved patient outcomes.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Background:
- Tuberculosis (TB) remains a significant global health threat.
- Recent advancements have introduced novel treatment strategies for TB.
- These include shorter regimens and new/repurposed antibiotics.
Purpose of the Study:
- To review recent developments in TB treatment.
- To explore the integration of shorter, oral therapies.
- To discuss the future role of precision medicine in TB management.
Main Methods:
- Literature review of recent clinical trials and research.
- Analysis of new and repurposed antibiotic efficacy.
- Examination of strategies for latent TB treatment.
Main Results:
- Shorter treatment regimens for latent TB improve adherence and reduce side effects.
- New and repurposed antibiotics offer effective, shorter treatments for drug-susceptible and drug-resistant TB.
- Atypical mycobacterioses also benefit from these advanced therapies.
Conclusions:
- Emerging TB treatments are predominantly oral and shorter.
- These therapies are expected to be combined with precision medicine.
- This integration promises more effective and personalized TB care.
More Related Videos
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Microorganisms in Medicine and Therapeutics